Sanofi has been stockpiling drugs for no-deal Brexit: WSJ

French drugmaker Sanofi (SASY.PA) has been making drug-shortage contingency plans for more than a year to prepare for Britain and the European Union failing to reach a Brexit transition deal, the Wall Street Journal reported on Tuesday, citing a source.